These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Tunnelled central venous line-associated infections in patients with pulmonary arterial hypertension treated with intravenous prostacyclin]. Boucly A; O'Connell C; Savale L; O'Callaghan DS; Jaïs X; Montani D; Humbert M; Simonneau G; Sitbon O Presse Med; 2016 Jan; 45(1):20-8. PubMed ID: 26547673 [TBL] [Abstract][Full Text] [Related]
8. Closed-hub systems with protected connections and the reduction of risk of catheter-related bloodstream infection in pediatric patients receiving intravenous prostanoid therapy for pulmonary hypertension. Ivy DD; Calderbank M; Wagner BD; Dolan S; Nyquist AC; Wade M; Nickels WM; Doran AK Infect Control Hosp Epidemiol; 2009 Sep; 30(9):823-9. PubMed ID: 19637961 [TBL] [Abstract][Full Text] [Related]
9. The "bouncing" catheter. Malaczynska-Rajpold K; Kurzyna M; Koteja A; Torbicki A; Mularek-Kubzdela T Cardiol J; 2016; 23(5):552-553. PubMed ID: 27723062 [No Abstract] [Full Text] [Related]
10. Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH Trial. Bourge RC; Waxman AB; Gomberg-Maitland M; Shapiro SM; Tarver JH; Zwicke DL; Feldman JP; Chakinala MM; Frantz RP; Torres F; Cerkvenik J; Morris M; Thalin M; Peterson L; Rubin LJ Chest; 2016 Jul; 150(1):27-34. PubMed ID: 27396777 [TBL] [Abstract][Full Text] [Related]
14. Central venous blood oxygen saturation monitoring in patients with chronic pulmonary arterial hypertension treated with continuous IV epoprostenol: correlation with measurements of hemodynamics and plasma brain natriuretic peptide levels. Chin KM; Channick RN; Kim NH; Rubin LJ Chest; 2007 Sep; 132(3):786-92. PubMed ID: 17646224 [TBL] [Abstract][Full Text] [Related]
15. Intravenous epoprostenol treatment of patients with connective tissue disease and pulmonary arterial hypertension at a single center. Shirai Y; Yasuoka H; Takeuchi T; Satoh T; Kuwana M Mod Rheumatol; 2013 Nov; 23(6):1211-20. PubMed ID: 23359006 [TBL] [Abstract][Full Text] [Related]
16. Totally Implantable IV Treprostinil Therapy in Pulmonary Hypertension Assessment of the Implantation Procedure. Waxman AB; McElderry HT; Gomberg-Maitland M; Burke MC; Ross EL; Bersohn MM; Pangarkar SS; Tarver JH; Zwicke DL; Feldman JP; Chakinala MM; Frantz RP; Thompson GB; Torres F; Rauck RL; Clagg K; Durst L; Li P; Morris M; Southall KL; Peterson L; Bourge RC Chest; 2017 Dec; 152(6):1128-1134. PubMed ID: 28583617 [TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 across the lung circulation in patients with pulmonary arterial hypertension and influence of epoprostenol infusion. Selimovic N; Andersson B; Bergh CH; Sakiniene E; Carlsten H; Rundqvist B J Heart Lung Transplant; 2009 Aug; 28(8):808-14. PubMed ID: 19632577 [TBL] [Abstract][Full Text] [Related]
18. Prevention of catheter-related infections using a closed hub system in patients with pulmonary arterial hypertension. Akagi S; Matsubara H; Ogawa A; Kawai Y; Hisamatsu K; Miyaji K; Munemasa M; Fujimoto Y; Kusano KF; Ohe T Circ J; 2007 Apr; 71(4):559-64. PubMed ID: 17384460 [TBL] [Abstract][Full Text] [Related]
19. Effects of continuous intravenous epoprostenol therapy on advanced primary pulmonary hypertension in Taiwanese patients. Hsu HH; Chen JS; Kuo SH; Chiang FT; Ko WJ; Kuo SW; Huang SC; Lee YC J Formos Med Assoc; 2005 Jan; 104(1):60-3. PubMed ID: 15660181 [TBL] [Abstract][Full Text] [Related]